A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation
Condition(s):Sarcoma; Neuroblastoma; Wilm’s TumorLast Updated:November 6, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Sarcoma; Neuroblastoma; Wilm’s TumorLast Updated:November 6, 2017Completed
Condition(s):Pancreas CancerLast Updated:December 15, 2023Not yet recruiting
Condition(s):Leukemia; Lung Cancer; Malignant Mesothelioma; Myelodysplastic Syndromes; Primary Peritoneal Cavity CancerLast Updated:March 2, 2016Completed
Condition(s):Wilms Tumor; Renal CancerLast Updated:February 21, 2023Not yet recruiting
Condition(s):Acute Myeloid Leukemia in RemissionLast Updated:March 3, 2021Recruiting
Condition(s):Myelodysplastic Syndromes; Acute Myeloid LeukemiaLast Updated:October 12, 2020Unknown status
Condition(s):High Grade Glioma; Diffuse Intrinsic Pontine GliomaLast Updated:January 30, 2023Active, not recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:July 7, 2020Completed
Condition(s):18F-FDG; Neuroblastoma; Hepatoblastoma; Wilms TumorLast Updated:March 19, 2024Completed
Condition(s):Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Acute Myeloid Leukemia; Donor; Hematopoietic Cell Transplant Recipient; HLA-A*0201 Positive Cells Present; Recurrent Acute Myeloid LeukemiaLast Updated:July 14, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.